Limiting Toxicity in Limited-Stage Hodgkin Lymphoma - 100303

Spotlight
Video

Limiting Toxicity in Limited-Stage Hodgkin Lymphoma

ash has 79 videos Subscribe Here

Loading........
Description: Hear findings, discussed by Jeremy Slade Abramson, MD, from a phase II trial comparing brentuximab vedotin with or without AVD radiation therapy for reducing the adverse effects of radiation and bleomycin for patients with limited-stage Hodgkin lymphoma.
Shared By : ash
Posted on : 10/08/15
Added : 3 years ago
Category : Hodgkin Lymphoma